WebDisclosure WebDisclosure
Basculer en Français
10233 Companies
211260 Keywords
141165 Articles
111903 Press releases
Headlines Articles Press releases OBI Pharma USA, Inc. Remove
  1. Home
  2. Companies
  3. OBI Pharma USA, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/15/2026 at 10:45, 2 days 3 hours ago

    OBI Pharma Presents Ten New Poster Sessions at AACR 2026

    Cancer Treatment ADC Technology OBI Pharma Tumor Heterogeneity GlycOBI® Platform
  • BRIEF

    published on 04/15/2026 at 10:45, 2 days 3 hours ago

    OBI Pharma présente dix nouvelles sessions d'affiches à l'AACR 2026

    Traitement Du Cancer Technologie ADC OBI Pharma Hétérogénéité Tumorale Plateforme GlycOBI®
  • PRESS RELEASE

    published on 04/15/2026 at 10:40, 2 days 3 hours ago

    OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies

    OBI Pharma showcases advancements in ADC technology at AACR 2026, highlighting GlycOBI platform. Poster presentations feature OBI-902, OBI-904, OBI-201, OBI-221, and novel Obrion technology
    Poster Presentations ADC Technology AACR 2026 OBI Pharma GlycOBI Platform
    Logo of OBI Pharma USA, Inc.
Accesswire
  • Published on 04/17/2026 at 13:35, 56 minutes ago

    Silver X Mining Corp. Announces Appointment of Mark NJ Ashcroft to Board of Directors

  • Published on 04/17/2026 at 13:00, 1 hour 31 minutes ago

    Meta Critical Minerals Announces Completion of Over Subscribed Private Placement With Strategic Advisory Support From Leading New York Investment Bank Revere Securities

  • Published on 04/17/2026 at 13:00, 1 hour 31 minutes ago

    Roxmore Resources Significantly Expands Land Position at Converse Gold Project By 70%

  • Published on 04/17/2026 at 12:00, 2 hours 31 minutes ago

    Dynamite Integrates Biometric Cryptography and AI into Its Wallet Product

  • Published on 04/17/2026 at 09:01, 5 hours 30 minutes ago

    Apex Critical Metals Included in Newly Launched Sprott Rare Earths ETF

View all ACCESSWIRE
EQS Group
  • Published on 04/17/2026 at 14:01, 29 minutes ago

    Amundi Physical Metals plc: UK Final Terms

  • Published on 04/17/2026 at 13:58, 32 minutes ago

    Amundi Physical Metals plc: Final Terms

  • Published on 04/17/2026 at 12:03, 2 hours 27 minutes ago

    Original-Research: FamiCord AG (von Montega AG): Buy

  • Published on 04/17/2026 at 11:39, 2 hours 51 minutes ago

    The autonomous factory: Schaeffler wins German Innovation Award for its Industrial Metaverse

  • Published on 04/17/2026 at 11:36, 2 hours 55 minutes ago

    Form 8.3 - Checkit PLC

View all EQS
Les Echos
  • Published on 04/17/2026 at 09:10, 5 hours 20 minutes ago

    Nombre total d'actions et droits de vote - mars 2026

  • Published on 04/17/2026 at 09:10, 5 hours 21 minutes ago

    Number of shares and voting rights - March 2026 (In French only)

  • Published on 04/16/2026 at 18:02, 20 hours 29 minutes ago

    Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026

  • Published on 04/16/2026 at 18:02, 20 hours 29 minutes ago

    Covivio - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 16 avril 2026

  • Published on 04/16/2026 at 18:00, 20 hours 31 minutes ago

    ICADE – PR – Q1 2026 TRADING UPDATE

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy